ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XOMAO XOMA Corporation

25.16
-0.1862 (-0.73%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
XOMA Corporation XOMAO NASDAQ Preference Share
  Price Change Price Change % Share Price Last Trade
-0.1862 -0.73% 25.16 15:07:16
Open Price Low Price High Price Close Price Previous Close
25.20 25.05 25.28 25.16 25.35
more quote information »

Recent News

Date Time Source Heading
6/12/202406:30GLOBEXOMA Receives $8.1 Million Milestone Related to Day One..
5/14/202406:30GLOBEXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect..
5/09/202406:30GLOBEXOMA Reports First Quarter 2024 Financial Results and..
4/30/202406:30GLOBEXOMA Adds Economic Interests in Three First-in-Category..
4/25/202406:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated..
4/03/202408:00GLOBEXOMA Corporation Announces Closing of Tender Offer
3/21/202406:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
3/19/202415:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
3/08/202406:30GLOBEXOMA Reports Fourth Quarter and Full Year 2023 Financial..
2/28/202406:30GLOBEXOMA to Present at Upcoming Investor Conferences in March
2/16/202407:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
1/18/202407:30GLOBEXOMA Expands its Commercial Royalty and Milestone Portfolio..
1/11/202415:05GLOBEFDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
1/08/202406:30GLOBEXOMA Names Owen Hughes as Chief Executive Officer and..
1/02/202406:30GLOBEXOMA Announces Stock Repurchase Program of up to $50 Million
12/20/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
12/19/202306:30GLOBEXOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
11/07/202306:30GLOBEXOMA Reports Third Quarter 2023 Financial Results and..
10/31/202306:30GLOBEXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
9/25/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
9/06/202306:30GLOBEXOMA to Present at H.C. Wainwright 25th Annual Global..
8/08/202306:30GLOBEXOMA Reports Second Quarter 2023 Financial Results and..
6/23/202317:14GLOBEXOMA Added to the Russell 2000® and Russell 3000® Indexes
6/22/202306:30GLOBEXOMA Acquires Royalty and Milestone Economics to Phase 3..
6/20/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends

Your Recent History

Delayed Upgrade Clock